Competition is driving innovation in monoclonal antibody manufacturing, say researchers, who predict that single-use technology will play an even greater role in production in years to come. Johnson & ...

SHANGHAI and GAITHERSBURG, Md., Jan. 28, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and ...

Continuous manufacturing makes monoclonal antibody production faster, cheaper, and greener, say researchers, who predict that industry adoption of the approach will accelerate in response to ...

Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive field studyExpect to ...

DURHAM, N.C.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the launch of SUREmAb™, an offering built on the robustness of KBI’s SUREtechnology Platform™, ...

DURHAM, N.C.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), announces a manufacturing contract ...

Leiden, The Netherlands – 11 December 2025 – ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G ...

As Emergent BioSolutions continues to pawn off manufacturing real estate in its pivot from production specialist to full-time drug developer, Indian CRDMO Syngene International is capitalizing on the ...

The MarketWatch News Department was not involved in the creation of this content. Leiden, The Netherlands -- 11 December 2025 -- ProteoNic BV, a leading provider of premium vector technology for ...